SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-000592
Filing Date
2019-01-11
Accepted
2019-01-11 17:25:07
Documents
1
Period of Report
2019-01-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K NOTICE OF FAILURE TO SATISFY A CONTINUED LISTING RULE snss-8k_20190111.htm 8-K 30847
  Complete submission text file 0001564590-19-000592.txt   32125
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 19523048
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1